Search Results - "Lishi, Sun"
-
1
PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph (-) Myeloproliferative Neoplasm: A Review
Published in International journal of molecular sciences (23-05-2022)“…There has been significant progress in immune checkpoint inhibitor (CPI) therapy in many solid tumor types. However, only a single failed study has been…”
Get full text
Journal Article -
2
TLR2 Derangements Likely Play a Significant Role in the Inflammatory Response and Thrombosis in Patients with Ph (-) Classical Myeloproliferative Neoplasm
Published in Mediators of inflammation (2024)“…We investigated the role of toll-like receptors (TLRs) in inflammatory pathways in Philadelphia chromosome-negative myeloproliferative neoplasms ( (-)MPNs)…”
Get full text
Journal Article -
3
SMARCA4-Deficient Undifferentiated Tumor of Lung Mass—A Rare Tumor With the Rarer Occurrence of Brain Metastasis: A Case Report and Review of the Literature
Published in JIM - high impact case reports (01-01-2022)“…Among thoracic tumors, these include subsets of a relatively newly described and yet to be fully characterized tumor entity: SMARCA4-deficient Undifferentiated…”
Get full text
Journal Article -
4
B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses
Published in The Journal of immunology (1950) (01-09-2010)“…CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) are immunopathogenic in cancers by impeding tumor-specific immunity. B7-homologue 1 (B7-H1) (CD274) is a…”
Get full text
Journal Article -
5
Mitigating Age-Related Immune Dysfunction Heightens the Efficacy of Tumor Immunotherapy in Aged Mice
Published in Cancer research (Chicago, Ill.) (15-04-2012)“…Although cancer tends to affect the elderly, most preclinical studies are carried out in young subjects. In this study, we developed a melanoma-specific cancer…”
Get full text
Journal Article -
6
eRapa Restores a Normal Life Span in a FAP Mouse Model
Published in Cancer prevention research (Philadelphia, Pa.) (01-01-2014)“…Mutation of a single copy of the adenomatous polyposis coli (APC) gene results in familial adenomatous polyposis (FAP), which confers an extremely high risk…”
Get full text
Journal Article -
7
Hemorrhagic Brain Metastasis as an Initial Presentation of Hepatocellular Carcinoma in a Patient With Alcohol-Related Liver Cirrhosis: A Case Report and Review of Literature
Published in JIM - high impact case reports (2022)“…Hepatocellular carcinoma (HCC) is the most common primary hepatic cancer. Although it usually presents as a liver mass, rarely HCC can have an initial…”
Get full text
Journal Article -
8
Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion
Published in JIM - high impact case reports (01-01-2023)“…T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive neoplasm that originates from mature post-thymic T-cells. Cutaneous manifestations are a common…”
Get full text
Journal Article -
9
Amyloidoma and Plasmacytoma Presented as a Solitary Lung Nodule in a Patient of Multiple Myeloma With AL-Amyloidosis: A Case Report and Review of Literature
Published in JIM - high impact case reports (01-01-2023)“…Nodular amyloidoma in the lungs is a rare entity, also the occurrence of extramedullary plasmacytoma (EMP) in the lungs is rare. To have concomitant EMP and…”
Get full text
Journal Article -
10
2413 Another Downside for Depression: A Case of SNRI-Induced Liver Injury
Published in The American journal of gastroenterology (01-10-2019)“…INTRODUCTION: Antidepressants are one of the most prescribed medications in the United States with duloxetine being reported as one of the top fifty drug…”
Get full text
Journal Article -
11
In Vitro Drug Studies of Inhibiting MDSC to Improve Efficacy of ICI (immune check point inhibitor) Therapy in Ph(-) myeloproliferative Neoplasm
Published in Blood (15-11-2022)Get full text
Journal Article -
12
Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
Published in Aging cell (01-12-2015)“…Summary The mammalian (mechanistic) target of rapamycin (mTOR) regulates critical immune processes that remain incompletely defined. Interest in mTOR inhibitor…”
Get full text
Journal Article -
13
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
Published in Clinical cancer research (01-07-2021)“…Immunotherapy treats some cancers, but not ovarian cancer. Regulatory T cells (Tregs) impede anti-ovarian cancer immunity but effective human Treg-directed…”
Get full text
Journal Article -
14
Morphological and functional alterations of astrocytes responding to traumatic brain injury
Published in Journal of integrative neuroscience (30-06-2019)“…Astrocytes, one of the most abundant and heterogeneous types of glial cell in the brain and spinal cord, are responsible for various essential functions in the…”
Get full text
Journal Article -
15
Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL‐17 producing T cells
Published in Aging cell (01-06-2012)“…Summary Regulatory T cells (Tregs) are specialized CD4+ T lymphocytes helping defend against autoimmunity and inflammation. Although age is associated with…”
Get full text
Journal Article -
16
Abstract LB-259: Interferon-α enhances clinical benefits of regulatory T cell depletion in ovarian cancer through direct T cell effects and by inducing bystander IL-6
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Tregs hinder anti-tumor immunity, and depleting them treats cancers effectively in mice. By contrast, Treg depletion in human trials has limited…”
Get full text
Journal Article -
17
B7-H1 blockade plus regulatory T cell depletion improves clinical efficacy over either strategy alone in a melanoma model (P4268)
Published in The Journal of immunology (1950) (01-05-2013)“…Abstract Denileukin diftitox (DD) is an FDA-approved conjugate of human IL-2 + diphtheria toxin. It depletes Tregs and improves clinical and immune outcomes,…”
Get full text
Journal Article -
18
Oral rapamycin (eRapa) safely prevents carcinogen-induced dermal carcinogenesis through an interferon-γ-dependent mechanism (TUM7P.931)
Published in The Journal of immunology (1950) (01-05-2014)“…Abstract eRapa extends life in mice and cancer prevention could be a mechanism. Rapamycin inhibits mTOR, which has significant immune effects that are…”
Get full text
Journal Article -
19
TMTP1, a Novel Tumor-homing Peptide, Specifically Targets Hematological Malignancies and Their Metastases
Published in Journal of Huazhong University of Science and Technology. Medical sciences (01-10-2011)“…TMTP1, a 5-amino acid peptide NVVRQ, obtained by using the flagella peptide library screening in our previous studies, can be used for the labeling of…”
Get full text
Journal Article -
20
Interferon-α augments the clinical efficacy of regulatory T cell depletion in ovarian cancer through direct and indirect T cell effects (VAC3P.941)
Published in The Journal of immunology (1950) (01-05-2014)“…Abstract Tregs blunt anti-tumor immunity, and their depletion effectively treats tumor in mouse cancer models. However, Treg depletion in human trials is only…”
Get full text
Journal Article